MedTrace Logo

Registry on WATCHMAN Outcomes in Real-Life Utilization WASP Registry

NCT01972295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 201

Last updated 2019-08-21

No results posted yet for this study

Summary

This is an observational, prospective, non-randomized, multicenter study with the following objectives: (1) to compile real-world clinical outcomes data for WATCHMAN Left Atrial Appendage Closure Technology in patients who are implanted with the WATCHMAN device in a commercial clinical setting and (2) to collect health care usage data that may be needed for reimbursement of WATCHMAN technology in certain countries.

Conditions

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Lynnett Voshage-Stahl · Boston Scientific Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-13
Primary Completion
2018-01-23
Completion
2019-03-31

Countries

  • Australia
  • Hong Kong
  • Indonesia
  • Malaysia
  • Saudi Arabia
  • South Korea
  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01972295 on ClinicalTrials.gov